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SUMMARY

Repetitive genomic regions include tandem sequence
repeats and interspersed repeats, such as endogenous retroviruses and LINE-1 elements. Repressive
heterochromatin domains silence expression of these
sequences through mechanisms that remain poorly
understood. Here, we present evidence that the retinoblastoma protein (pRB) utilizes a cell-cycle-independent interaction with E2F1 to recruit enhancer of
zeste homolog 2 (EZH2) to diverse repeat sequences.
These include simple repeats, satellites, LINEs, and
endogenous retroviruses as well as transposon fragments. We generated a mutant mouse strain carrying
an F832A mutation in Rb1 that is defective for recruitment to repetitive sequences. Loss of pRB-EZH2
complexes from repeats disperses H3K27me3 from
these genomic locations and permits repeat expression. Consistent with maintenance of H3K27me3 at
the Hox clusters, these mice are developmentally
normal. However, susceptibility to lymphoma suggests that pRB-EZH2 recruitment to repetitive elements may be cancer relevant.

INTRODUCTION
Repetitive genomic regions comprise approximately 50% of
the human genome (Lander et al., 2001). These repetitive elements include tandem repeats, such as satellite sequences
that underpin the heterochromatin at centromeres, in addition
to interspersed repeats that are capable of transposition (Slotkin and Martienssen, 2007). Expression of repetitive elements
poses a mutagenic threat to the host through multiple possible
aberrations (Mager and Stoye, 2015). For example, de-repres-

sion of satellite repeats disrupts organization of centromeric
heterochromatin and coincides with defects in chromosome
segregation and meiosis (Slotkin and Martienssen, 2007). At
the transcriptional level, de-repressed repeat sequences can
serve as alternate enhancers or promoters that permit ‘‘readthrough’’ transcription and cis-activation of proximal genes,
including proto-oncogenes that have been established as initiating events in human lymphomas (Lamprecht et al., 2010).
More recently, sequencing-based studies demonstrate that
re-integration of activated mobile repetitive elements can
generate cancer-relevant mutations in pre-malignant lesions
that precede various human cancers (Helman et al., 2014; Iskow et al., 2010; Lamprecht et al., 2010; Lee et al., 2012;
Lock et al., 2014). Likewise, re-integration of activated satellites
expands centromere repeats and can fuel cancer cell growth
(Bersani et al., 2015). The frequent co-occurrence of repetitive
element reactivation with genome instability suggests that
the antagonism of repeat silencing may be achieved through
mechanisms commonly employed to initiate tumorigenesis.
Recent evidence of p53-mediated transposon repression indicates that this may indeed be the case (Leonova et al., 2013;
Wylie et al., 2016). Thus, any potential contribution of repetitive
sequences to cancer initiation must ultimately be mitigated
through transcriptional silencing. Understanding how silencing
is achieved is fundamental to understanding how cancerinitiating mechanisms may circumvent this facet of genome
regulation.
Repetitive elements are transcriptionally repressed by DNA
methylation and histone tail modifications (Schlesinger and
Goff, 2015). Sustained repression of repetitive elements
during periods of genome-wide DNA hypomethylation in early
embryogenesis has stimulated investigation of histone-dependent repression mechanisms in embryonic stem cells (ESCs)
(Leung and Lorincz, 2012; Levin and Moran, 2011). Repetitive
sequences in ESCs are enriched for H3K9me2/3, H4K20me3,
and H3K27me3 (Day et al., 2010). Upon loss of DNA
methylation, H3K27me3 expands to maintain silencing of
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interspersed and tandem repeat sequences (Walter et al.,
2016). Following genetic ablation of H3K9 histone methyl
transferases, H3K27me3 compensates for H3K9me3 loss at
interspersed and pericentromeric repeats (Peters et al.,
2003). However, additional deletion of the Polycomb repressor
complex 2 (PRC2) subunit EED can deregulate these repetitive sequences, indicating redundancy of repressive mechanisms (Walter et al., 2016). Proteomic analysis of ESCs indicates that 60% of histone H3 proteins are composed of
H3K27me2/3 modifications (Peters et al., 2003). Collectively,
these data suggest H3K27me3-based heterochromatinization provides a dynamic epigenetic mechanism that silences
repeat sequence expression in response to alterations in other
silencing mechanisms and likely contributes extensively on its
own (Bulut-Karslioglu et al., 2014; Karimi et al., 2011; Liu et al.,
2014). Despite this fundamental contribution to genome-wide
repeat silencing, little is known about the mechanism of
H3K27me3 deposition and expansion at repetitive sequences
because investigation of Polycomb at non-unique genomic regions primarily concerns the regulation of neighboring genes
(Bauer et al., 2015; Casa and Gabellini, 2012). Beyond ESCs,
investigation of repetitive DNA silencing by PRC2 remains
even less understood.
Dynamic response to various genomic alterations positions
Polycomb as a robust barrier to reactivation of repeat sequences. Thus, disruption of genome stability through repeat
sequence resurrection likely requires disruption of Polycombmediated heterochromatin. A surprising link among Polycomb,
repetitive sequences, and cancer-initiating mechanisms may
be the RB tumor suppressor protein (pRB). Although pRB
is best known as a repressor of E2F transcription factors at
cell-cycle genes, pRB family proteins also direct H3K27me3
to repress transcription during differentiation and stress (Blais
et al., 2007; Bracken et al., 2007; Kareta et al., 2015; Kotake
et al., 2007). In addition, RB-cell-cycle-independent interactions with chromatin (Avni et al., 2003; Wells et al., 2003)
have been observed, but genome-wide analysis of pRB at
repeat sequences is lacking (Coschi et al., 2014; Montoya-Durango et al., 2009). Thus, there is no evidence pRB-mediated
regulation of H3K27me3 is sufficiently widespread to match
the magnitude of H3K27me3 abundance and distribution at
repeats.
In this study, we demonstrate that pRB and enhancer of zeste
homolog 2 (EZH2) form a complex that directs H3K27me3
deposition at most repeat element types from simple sequence
repeats and satellites to DNA transposons, long interspersed
nuclear elements (LINEs), short interspersed nuclear elements
(SINEs), and endogenous retroviruses. We report the generation
of a strain of mice carrying a targeted point mutation, F832A
(called Rb1S), which is specifically defective for recruitment of
EZH2 to repetitive sequences. In the absence of pRB recruitment, EZH2 no longer directs H3K27me3 to these elements,
leading to dispersion or loss of heterochromatin. Rb1S/S fibroblasts and splenocytes express diverse repeat sequences,
including tandem and interspersed elements, and aged Rb1S/S
mice develop spontaneous lymphomas. Collectively, these
data suggest that silencing of repetitive elements contributes
to pRB’s function as a tumor suppressor.

RESULTS
pRB Occupies Repetitive Genomic Sequences
To explore emerging chromatin regulatory functions beyond cellcycle control, we compared pRB association with chromatin in
arrested and proliferating mouse embryonic fibroblasts (MEFs).
While noticeably reduced, pRB retains some chromatin binding
in proliferating cells (Figure 1A). We sought to further investigate
genome-wide distribution of pRB across growth conditions by
chromatin immunoprecipitation-sequence analysis (ChIP-seq).
We used a stringent sequence alignment approach that prohibited mismatches and randomized read assignments where
more than one exact match existed to enhance potential alignments to repetitive regions (see Experimental Procedures and
Bulut-Karslioglu et al., 2014). Analysis of distribution across
broad genomic regions reveals a dramatic abundance of peaks
in introns and intergenic locations (Figure 1B), with distribution
proportions unaltered by proliferative status. This suggests that
despite reduced pRB chromatin occupancy in proliferating cells,
this pRB distribution pattern displays cell cycle independence at
these regions. Comparison of enrichment at wild-type peak locations within promoters of Rb1/ controls confirms a high degree
of stringency in peak assignment (Figure 1C). Because an
abundance of peaks localize to non-coding regions, we next
annotated peaks on the basis of categories of repetitive sequences (Figure 1D). Analysis of peak distribution reveals pRB
association with SINEs, long terminal repeat (LTR)-containing
endogenous retroviruses (ERVs), LINEs, and simple repeat sequences, among others. Importantly, these surprising findings
are mirrored in a meta-analysis of a recently published human
pRB ChIP-seq study (Figures 1B and 1D) (Ferrari et al., 2014).
The RB protein is best known for its regulation of E2F-responsive cell-cycle genes, and our mapping of ChIP-seq reads detects these promoter occupancy events in mouse and human
datasets (Figures 1E and 1F). Repeat occupying peaks are
also found in neighboring regions of the same chromosomes
(Figures 1G and 1H). Our analysis of peak distribution in murine
cells demonstrates that at least two-thirds of pRB-occupying
peaks map to repetitive sequences (Figures 1B and 1D). It is
difficult to draw a similar conclusion in human data because
many pRB peaks contain multiple repetitive elements in the
same peak (Figure 1H). Collectively, these data indicate that
pRB associates with diverse repetitive elements in mouse and
human fibroblasts.
Loss of a CDK-Resistant pRB-E2F1 Interaction Disrupts
Repeat Association
We previously identified a pRB-E2F1 interaction that confers
reduced binding to consensus E2F sequence elements and
resistance to disruption by cyclin dependent kinase (CDK) phosphorylation (Cecchini and Dick, 2011; Dick and Dyson, 2003). We
sought to determine whether the properties of this interaction
could underlie the cell-cycle-independent pRB occupancy
observed in our ChIP-seq. We generated a targeted mutant
mouse strain bearing an F832A substitution to disrupt the unique
pRB-E2F1interaction and named this allele Rb1S (Figures S1A–
S1D, available online). Rb1S/S mice are indistinguishable from
littermates (Figures S1E and S1F), and Rb1S/S cells exhibit
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Figure 1. pRB Associates with Genomic Repeats in Murine and Human Fibroblasts
(A) pRB western blots of MEF chromatin fractions. Coomassie-stained histones indicate relative chromatin quantities.
(B) Overall genomic distribution of pRB ChIP-seq peaks per growth condition; n = 424,588 peaks and n = 77,809 peaks for mouse pRB in arrested and proliferating MEFs respectively; n = 71,511 peaks for human pRB in arrested IMR90 cells.
(C) Heatmaps display scaled pRB ChIP-seq read buildups at proximal promoter regions occupied by wild-type pRB peaks. Each row contains ± 1 kb of flanking
sequence. The intensity scale indicates the read enrichment level.
(D) Percent distribution of pRB ChIP-seq peaks per repeat class; n = 321,892 peaks for mouse pRB arrested, n = 49,210 peaks for mouse pRB proliferating, and
n = 99,186 peaks for human pRB arrested.
(E) Genome viewer tracks display mouse pRB ChIP-seq reads at Ccne2, with genomic coordinates above. Repeat Masker and RefSeq tracks are shown below.
Red bars denote peaks.
(F) The analogous region of human CCNE2 is shown and labeled akin to (D).
(G) Example of mouse pRB occupancy at a LINE-1 element 30 of the Ccne2 gene.
(H) Example of a human pRB peak 50 of CCNE2 that simultaneously overlaps multiple repeat elements.
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ostensibly normal expression levels of pRB and RB family
proteins (Figure 2A). pRBS demonstrates a specific defect
in binding the E2F1 coiled coil and marked box domain, without
effects on E2F transactivation domain binding (Figures S2A–
S2D). Consistent with this, cell-cycle regulation and E2F target
gene expression are indistinguishable from wild-type controls
(Figures S2E–S2G).
Western blots of chromatin fractions reveal diminished pRBS
association with chromatin under both proliferating and arrested
conditions (Figure 2A). ChIP-qPCR was performed to assess
pRB recruitment at the cell-cycle-responsive Mcm3 promoter.
In addition to Rb1S/S cells, we utilized the previously characterized
Rb1G mutant that disrupts canonical pRB-E2F transcriptional
control through R461E and K542E substitutions for comparison
(Cecchini et al., 2014) (Figure 2B). Under arrested conditions,
the pRBS protein exhibits a similar association with the Mcm3
transcriptional start site (TSS) as wild-type pRB, whereas the
pRBG mutant exhibits reduced occupancy. Under proliferating
conditions, wild-type and pRBS occupancy of the Mcm3 promoter
diminishes, which is consistent with CDK-dependent regulation
of pRB-E2F interactions at this genomic location.
Given the retention of pRBS at E2F cell-cycle targets, but
the clear loss of chromatin association revealed by fractionation,
we conducted ChIP-seq for pRB in Rb1S/S cells to discover
genomic locations that require this pRB-E2F1 interaction.
Because pRBS chromatin association was globally reduced
in Figure 1A, we focused our analysis on wild-type locations
lost in Rb1S/S cells. Under both growth conditions, ChIP-seq in
Rb1S/S fibroblasts uncovers a dramatic loss of pRB enrichment
at repetitive elements occupied by wild-type pRB that is equally
evident by ChIP-qPCR (Figures 2C–2E). Comparison of read
buildups at wild-type peak locations reveals that pRBS localization is disrupted at the vast majority of elements in these repClass
groups (Figure 2C). Quantitatively, greater than 80% of wild-type
pRB peak intersections at repetitive elements are lost in Rb1S/S
chromatin under both growth conditions (Figure S3A).
In contrast to repetitive elements, the pRBS enrichment
profile at E2F cell-cycle genes parallels that of wild-type pRB
(Figure S3B). Interestingly, pRB localizes extensively to repeatcontaining regions within 1 kb of non-E2F target genes
and pRBS exhibits a loss of enrichment at these repeat-containing regions under both growth conditions (Figure S3C).
ChIP-qPCR for pRB at major satellites, LTR-containing, and
non-LTR retrotransposon repeat classes confirms diminished
pRBS occupancy at repetitive elements, whereas the pRBG
mutant parallels the cell-cycle-independent occupancy displayed by wild-type pRB at these elements (Figure 2D). Genome
browser tracks show two examples of pRB peak loss in Rb1S/S
cells at fragments of LINE-1 elements (Figure 2E). Lastly, ChIPqPCR detects E2F1 at these repetitive sequences, which
is consistent with a model of E2F1 contributing to pRB localization at repeats (Figure S3D).
Collectively, these data indicate that disrupting pRB’s CDKresistant binding site for E2F1 prevents its localization to repetitive regions of the genome. Analysis of mutant forms of pRB with
distinct defects for E2F interaction type across different growth
conditions further supports the conclusion that pRB possesses
a cell-cycle-independent mechanism for repeat occupancy

that is distinct from its transcriptional regulatory role during the
G1-S phase transition.
pRB-Repeat Association Is Required to Silence
Repetitive Sequence Expression
To investigate the functional role of repeat occupancy by pRB, we
performed RNA-seq on arrested MEFs. Total RNA was depleted
of rRNA prior to library construction, and reads were aligned to
repeat indices and binned according to repeat classification
and family. The number of reads in each category was normalized
to the total number of aligned reads per sample. Columns display
expression from three separate Rb1S/S MEF preparations as a
log2 ratio normalized to the average of three wild-type samples
(Figure 3A). Rb1S/S MEFs exhibit increased expression of type I
and type II transposable elements, satellites, and simple repeats
in all three biological replicates. In two mutant samples,
many families of LTR-containing repeats, DNA transposons,
LINEs, and SINEs show widespread deregulation. Collectively,
this demonstrates transcriptional misregulation of repeats that
matches the repeat occupancy pattern of pRB. We note variability of expression in sample C5137_E3; however, broad differences between biological replicates are common to investigations of repeat sequence expression (Howard et al., 2008;
Muotri et al., 2010; Wylie et al., 2016), and limited misregulation
appears specific to this MEF preparation alone.
Representative elements from highly deregulated repeat classes were selected to further explore pRB-repeat regulation.
Mapping sequence reads to instances of LINE-1, IAP, and major
satellite sequences confirms increased read abundance across
these elements (Figure 3B). Furthermore, elevated transcript
levels from major satellites, LINE-1 elements, and intracisternal
A particle (IAP) endogenous retroviruses are readily detectable
in arrested and proliferating cultures of Rb1S/S MEFs by qRTPCR (Figures 3C and S4A). Elevated LINE-1 50 UTR and IAP
LTR-containing transcript levels are consistent with full-length
element expression (Figures 3B and 3C). Again, we note that
MEFs from embryo C5137_E3 are refractory to expression in
three separate analyses of these cells. Microarray analysis was
performed to compare the specificity of endogenous retroviral
expression in Rb1S/S cells with other structure-function mutants
of pRB that disrupt binding to the E2F transactivation domain
(Rb1G/G) or to LXCXE-motif-containing proteins (Rb1L/L). This
analysis reveals increased expression of repeats specifically in
the Rb1S/S mutant and not the other genotypes (Figure 3D).
Importantly, expression of canonical E2F target genes appears
increased in only Rb1G/G and Rb1L/L cells (Figure S4B), further
emphasizing the unique alteration in gene expression found in
Rb1S/S mutants.
These experiments demonstrate that pRB occupancy of
repetitive sequences functionally contributes to their silencing
because loss of binding correlates with increased expression
of a wide array of repeats that are detectable using multiple
expression-profiling methods. Curiously, many examples of
pRB occupancy in Figures 1 and 2 are fragments of repetitive
elements that may not be capable of autonomous expression.
This suggests that this pRB-dependent silencing mechanism is
broad and indiscriminate both in the elements that it silences
and their potential for expression.
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Figure 2. Cell-Cycle-Independent pRB-Repeat Association
(A) Western blots of whole-cell extracts display expression levels of wild-type and the F832A mutant (Rb1S) pRB as well as p107 and p130. pRB western blot of
chromatin fractions from arrested and proliferating cells. Coomassie-stained histones indicate loading.
(B) pRB ChIP-qPCR at the Mcm3 TSS and 2 kb 50 of Mcm3.
(C) Heatmaps of pRB ChIP-seq read enrichment per repClass. Each row represents one scaled wild-type peak location at an element within the repClass and
includes ± 1 kb of flanking sequence. Intensity scale indicates magnitude of read enrichment.
(D) pRB ChIP-qPCR at the indicated repetitive elements.
(E) Representative genomic regions with pRB repeat association at LINE-1 fragments. Red bars denote peaks. For all graphs, error bars indicate one SD from the
mean, and an asterisk represents a significant difference from wild type (p % 0.05 by t test). See also Figures S1–S3.
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Figure 3. pRB Silences Repetitive Element Expression
(A) Heatmap of repeat expression from three Rb1S/S MEF preparations relative to the average of three wild-type replicates. RNA-seq reads were aligned to repeat
indices, binned according to repClass and repFamily, and normalized to the total number of aligned reads in the sample. Expression was quantified as a log2 ratio
relative to the average of three wild-type replicates.
(B) RNA-seq reads aligned to instances of LINE, IAP endogenous retrovirus, and major satellite repeats.
(C) qRT-PCR of the indicated repetitive elements in proliferating MEFs plotted as log2 of the ratio, with wild type using actin as an internal control. Each MEF pair
was cultured independently three times and expression levels for each replicate are shown to illustrate variability in expression between culture and genotypes.
(D) Expression microarrays performed with RNA from arrested MEFs. Log2 values of mutant/wild type shown as a heatmap depict expression levels of
endogenous retrovirus-detecting probe sets. See also Figure S4.

H3K27me3 Enrichment at Repetitive Sequences Is pRB
Dependent
DNA methylation and histone modifications contribute to both
redundant and non-redundant silencing of repetitive elements.
The contribution of each was assessed in mutant fibroblasts.
ChIP was used to detect histone tail modifications regulated

by pRB and present at repetitive elements in ESCs. Although
H4K20me3 and H3K9me3 enrichment remain unchanged at
major satellites, LINEs, and LTR-containing endogenous retroviruses (Figures S5A and S5B), a prominent reduction of
H3K27me3 appears evident in Rb1S/S cells (Figure 4A). Beyond
methylation, Rb1S/S cells exhibit elevated H3K9Ac enrichment
Molecular Cell 64, 1074–1087, December 15, 2016 1079

Figure 4. H3K27me3 Enrichment at Repetitive Elements Is pRB Dependent
(A) ChIP-qPCR for H3K27me3 in arrested MEFs. Error bars indicate one SD from the mean. An asterisk represents a significant difference from wild type (p % 0.05
using a t test).
(B) Overall genomic distribution of H3K27me3 ChIP-seq peaks per growth condition; n = 656,342 peaks in arrested cells; n = 143,252 peaks in proliferating cells.
(C) Genome viewer tracks depict H3K27me3 read buildup at L1 elements (highlighted by red boxes), with genomic coordinates and scale above tracks.
(D) H3K27me3 distribution at a Hox gene cluster.
(E) Heatmaps of H3K27me3 read enrichment per repClass. Each row represents one scaled wild-type peak location at an element within the repClass and
includes ± 1 kb of flanking region. Intensity scale indicates magnitude of read enrichment. See also Figures S5 and S6.

at these repetitive elements, and de-repression by Trichostatin A
further suggests that histone de-acetylation functionally contributes to this regulation (Figure S5C). In contrast, H19 and
Gapdh maintain equivalent enrichment of these histone tail
modifications between genotypes.

1080 Molecular Cell 64, 1074–1087, December 15, 2016

We performed ChIP-seq for H3K27me3 to expand upon
the pRB dependence observed at repetitive elements by
ChIP-qPCR. Similar to pRB, the vast majority of wild-type
H3K27me3 peaks reside within intronic and intergenic regions,
irrespective of proliferative status (Figure 4B). A number of

distinct effects of the Rb1S/S mutation on H3K27me3 distribution
emerge from these data. H3K27me3 reductions are readily
observed in sequence tracks over repeat-rich intergenic regions
(Figure 4C). Many canonical genes regulated by H3K27me3,
such as in Hox clusters, Cdkn2a, and Sox2, retain normal
H3K27me3 enrichment in Rb1S/S MEFs (Figures 4D and S5D).
Comparison of H3K27me3 read buildup at wild-type peak locations across repeat classes reveals diminished enrichment in
Rb1S/S cells, particularly under arrested growth conditions (Figure 4E). However, some individual repeat elements disperse or
broaden their H3K27me3 distribution, and this is more common
in proliferating cells. Comparison of peak intersections at repetitive elements reveals that 75% of wild-type H3K27me3 peaks
in repeat regions are lost in Rb1S/S cells across both growth
conditions (Figure S5E). Retention of reads at many repeats
in proliferating Rb1S/S cells (Figure 4E) at magnitudes below
the threshold of peak calling suggests that H3K27me3 becomes
dispersed, but not altogether lost, under proliferating conditions.
Elevated repeat expression in proliferating Rb1S/S cells (Figure 3C) suggests this dispersion represents compromised
silencing by H3K27me3.
These data demonstrate a broad mechanism of heterochromatinization among many distinct repeat element types. DNA
methylation is perhaps the only other mechanism as indiscriminate in its repertoire of target sequences. Therefore, we investigated DNA methylation by bisulfite sequencing to determine if
H3K27me3 and DNA methylation may be functionally related
by pRB. Amplification of the same families of LINE-1 and
IAP LTR viruses, as in Figures 2D and 3C, bears no obvious
DNA methylation differences in Rb1S/S MEFs (Figures S6A
and S6B). Following DNA methylation inhibition by 5-aza cytidine, repeat sequence expression increases in Rb1+/+, but not
Rb1S/S, MEFs, suggesting that they are already de-repressed
(Figure S6C).
Our data reveal a dramatic loss of H3K27me3 organization
at repetitive sequences. H3K27me3 loss is similar in magnitude to loss of pRB at repeat sequences in Rb1S/S fibroblasts.
Our data further suggest that DNA methylation alterations
do not underlie widespread changes to heterochromatin in
Rb1S/S cells. For this reason, we interpret our experiments to
be indicative of a mechanism for silencing repetitive DNA sequences that acts in parallel to DNA methylation in primary
fibroblasts.
pRB-Chromatin Association Is Required for EZH2
Recruitment to Repetitive Sequences
The polycomb repressor 2 complex (PRC2) contains the EZH2
histone methyltransferase that methylates H3K27 to establish
the trimethylation mark. We explored whether pRB-dependent
regulation of EZH2 might underlie epigenetic and transcriptional
changes observed in Rb1S/S cells.
ChIP-seq was used to determine whether EZH2 association at
repeat elements was affected in growth-arrested Rb1S/S cells.
This analysis reveals that EZH2 also displays primarily intronic
and intergenic distribution (Figure 5A). Across all repeat classes,
wild-type locations of EZH2 enrichment diminish in Rb1S/S MEFs
(Figure 5B), with more than 80% of wild-type peak intersections
at repetitive elements lost in Rb1S/S fibroblasts (Figure S7A).

ChIP-qPCR confirms pRB-dependent EZH2 association with
major satellites, LINEs, and endogenous retroviral sequences
(Figure 5C). Because pRB and E2Fs control EZH2 expression
(Bracken et al., 2003; Jung et al., 2010), we confirm EZH2 levels
remain unchanged in Rb1S/S MEFs, and therefore do not mislead
our investigation (Figure S7B). pRB-dependent EZH2 localization suggests regulation beyond transcriptional control of
EZH2. Indeed, ChIP-reChIP indicates that EZH2 and pRB
co-localize at LINE-1 and IAP LTRs, whereas association
in Rb1S/S MEFs is comparable to background (Figure 5D).
Co-immunoprecipitation demonstrates that both wild-type and
pRBS bind EZH2 (Figure S7C). In addition, ChIP-reChIP reveals
that E2F1 deficiency prevents pRB and EZH2 co-localization to
LINE-1, IAP, and major satellite repeats (Figure S7D). Collectively, this suggests a model whereby pRBS can bind EZH2 but
fails to localize to repetitive sequences because of its deficiency
for binding E2F1, whereas wild-type pRB is capable of both
EZH2 and E2F1 interactions, leading to H3K27me3 deposition
at repetitive locations (Figure 5E).
Our data indicate that pRB, E2F1, and EZH2 are capable of
forming a complex at repetitive genomic regions. However,
although peak intersections between pRB and EZH2 at repetitive
sequences in Rb1S/S cells assert a genetic requirement for pRB
to recruit EZH2, they do not co-localize stoichiometrically
(Figures S7E and S7F). This suggests that pRB and E2F1 may
recruit EZH2 initially, but subsequent spreading of EZH2 and
H3K27me3 may occur independent of pRB.
Rb1S/S Mice Succumb to Spontaneous Lymphoma
To determine where this repeat silencing mechanism is most
relevant, we assessed repeat expression in tissues of adult
mice using qRT-PCR (Figure 6A). For most tissues, expression
varies between individuals, with no consistent trend relative to
wild-type controls. However, four of eight Rb1S/S mice display
elevated levels of all repeats tested in the spleen (F241, F242,
F248, and F307), whereas only one of eight wild-type mice
expresses repeats in this tissue (F233). This suggests that
pRB-dependent silencing may be most relevant in the spleen.
However, a survey of major tissues in these mice, including
the spleen, reveals no obvious histological differences. Given
that expression of repetitive sequences stimulates an immune
response to eliminate these cells, we searched for evidence of
interferon activation. Figure 6B shows qRT-PCR analysis of
Ifn-a and Ifn-b expression in splenocytes. Again, expression
varies among individuals, but we note that two Rb1S/S mice
display high-level expression of both (F296 and F307), further
suggesting that Rb1S/S mice respond to abnormal repeat
expression in their splenocytes. Conversely, this magnitude of
interferon response is largely absent from wild-type mice.
Because normal mammalian immune function seeks to eliminate
repeat misexpressing cells, we further sought evidence of
altered repression by investigating H3K27me3 deposition
at repetitive sequences in splenocytes. ChIP-qPCR assays
demonstrate that H3K27me3 is reduced at IAP ERVs, LINE-1 elements, and major satellites, but H3 levels remain comparable
between genotypes (Figure 6C). These experiments suggest
that H3K27me3 is altered in chromatin from Rb1S/S splenocytes
and that repeats can be misexpressed, but these cells are likely
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Figure 5. pRB-Chromatin Association Mediates EZH2 Recruitment to Repetitive DNA
(A) Overall genomic distribution of EZH2 ChIP-seq peaks in arrested wild-type MEFs; n = 840,543 peaks.
(B) Heatmaps of EZH2 read enrichment per repClass. Each row represents one scaled wild-type peak location at an element within the repClass that includes ±
1 kb of flanking region. Intensity scale indicates level of read enrichment.
(C) EZH2 ChIP-qPCR at repeats.
(D) EZH2-pRB ChIP-reChIP at repeats, with genetic knockouts as controls.
(E) Two genomic regions depict ChIP-seq tracks for EZH2, pRB, and H3K27me3 in arrested MEFs, with genomic coordinates and scale above tracks. Red boxes
highlight peak overlaps across datasets. For all graphs, error bars indicate one SD from the mean. An asterisk represents a significant difference from wild type
(p % 0.05 using a t test). See also Figure S7.

unable to accumulate in young adult mice with a functional
immune system.
To determine the long-term consequences of the Rb1S mutation, we generated cohorts of Rb1S/S mutant mice and wildtype siblings to monitor over the course of their lifetime for
the manifestation of pathology. Mutant mice exhibit a significantly reduced tumor-free survival, with a median lifespan of
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576 days (Figure 7A). Necropsy and histopathological analysis
reveals that the majority of mice succumb to lymphomas, particularly in the spleen and mesenteric lymph node (Figure 7B).
Examples of lesions evident upon necropsy are shown in
Figure 7C as well as the normal abdominal cavity of an unaffected wild-type mouse at 2 years of age. The corresponding
histology for each example is shown (Figure 7D). In addition,

Figure 6. Altered Chromatin and Repeat Expression in Rb1S/S Splenocytes
(A) Heatmap of repeat element expression per tissue of 6- to 8-week-old mice quantified by qRT-PCR. Log2 ratio of expression is displayed relative to the average
of all wild-type measurements for a given element in each tissue.
(B) Heatmap of interferon gene expression in splenocytes from the same mice.
(C) H3K27me3 and H3 ChIP-qPCR from freshly harvested splenocytes of 6-week-old mice. Error bars indicate one SD from the mean (n = 3; an asterisk indicates
p < 0.05, t test).

qRT-PCR of RNA derived from these tumor samples indicates
that diverse repetitive sequences are expressed in these malignancies (Figure S7G). This suggests that pRB’s ability to form
complexes with E2F1 at repetitive sequences and establish
H3K27me3-dependent silencing is highly relevant to its tumor
suppressive functions.
Collectively, our work suggests a model in which pRB recruits
EZH2 to repeat sequences, where it catalyzes H3K27me3 to
silence expression, and a point mutation in pRB that blocks
localization to these sequences prevents recruitment of EZH2
and causes dispersion of H3K27me3. Endogenously, this mechanism is important in splenocytes, where deregulated expression of repeats is most detectable, and these cells eventually
give rise to lymphomas in older Rb1S/S mice.
DISCUSSION
Our data reveal a mechanism, in which pRB and EZH2 cooperate
to establish H3K27me3, which silences expression of genomic
repeat sequences. This mechanism is largely indiscriminate
because it silences tandem repeats in addition to retrotransposons. These characteristics indicate that pRB-EZH2-dependent
silencing of repeats plays a broad but previously unappreciated
role in genome organization.

Investigation of Polycomb-based repeat regulation by
H3K27me3 in mammals primarily concerns critical steps of
early embryonic development (Leeb et al., 2010; Macfarlan
et al., 2012). Misregulation typically manifests in defects that
prevent embryonic development before implantation (Leeb
et al., 2010; Macfarlan et al., 2012) or that have overt consequences in adult mice (Li et al., 2015). Lack of developmental
impediments in Rb1S/S mice and retention of H3K27me3 at
developmentally regulated loci, such as Hox genes and Sox2,
suggests the pRB-EZH2 complex must be recruited to repeats
through a mechanism that is distinct from previous studies,
or this pRB-dependent mechanism is not functional in cells
during early development.
Comprehensive understanding of the Polycomb function requires detailed elucidation of chromatin recruitment mechanisms (Bauer et al., 2015; Casa and Gabellini, 2012). Previous
studies demonstrate that non-coding transcripts can target
Polycomb repressor complexes to specific loci, as observed
upon X chromosome inactivation (Blackledge et al., 2015).
Based on the co-immunoprecipitation of pRB and EZH2 and
their co-occupancy of repeats by ChIP-reChIP, it is likely that
pRB directly recruits EZH2 to repeats. Diminished pRB binding
to repeats in Rb1S/S cells results in loss of EZH2 and
H3K27me3 peaks, but our data also suggest that EZH2 may
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Figure 7. Aged Rb1S/S Mice Are Tumor Prone
(A) Kaplan-Meier plot of tumor-free survival for cohorts of mice aged until animal protocol endpoint. Tick marks indicate mice necropsied at intermediate ages.
Mutant mice are significantly more cancer prone than wild-type mice (log rank test, p < 0.05).
(B) Anatomical location and cancer type listed by frequency of occurrence.
(C) Peritoneal cavity images upon necropsy. A white arrow indicates an abnormal mass in the spleen of mouse C6217. A dashed line highlights the mesenteric
lymph node of mouse C6209. A white arrow indicates an abnormal liver, and a black arrow indicates a normal lobe in mouse C5360.
(D) H&E staining of tissue sections from the abnormality indicated in the mutant animals above. A black arrow indicates the lymph node in mouse C6209. The scale
bars represent 300 mm.

not stably associate with pRB at all of these locations and may
spread H3K27me3 heterochromatin without it.
Beyond non-coding RNAs, sequence specific transcription
factors can recruit Polycomb to specific genomic locations to
initiate such nucleation and spreading (Bauer et al., 2015;
Casa and Gabellini, 2012). Our study indicates that E2F1 can
fulfill this role, and although some repeats contain consensus
E2F elements (Montoya-Durango et al., 2009), E2F1 site selection appears increasingly diverse in the post-genomic era
(Bieda et al., 2006; Biswas and Johnson, 2012). Our initial identification of pRB’s unique interaction with E2F1 was based on
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the inability of this complex to recognize a consensus E2F promoter element (Dick and Dyson, 2003). Major satellite repeats
exemplify this in vivo where GC-rich consensus E2F elements
are missing, but pRB and E2F1 bind cooperatively, such that
E2F1 binding is greatly diminished without pRB (Coschi et al.,
2014). Therefore, pRB-E2F1 interactions underlie recruitment
of Polycomb to repeats; however, a recognition mechanism
for E2F1 at the variety of repeat sequences identified remains
unclear and is highly reminiscent of searches for Polycomb
response elements in mammalian gene promoters (Bauer
et al., 2015).

The cancer susceptibility of Rb1S/S mice suggests a
role for pRB-EZH2 in genome maintenance and tumor suppression. This begs the question of how this mechanism
functions endogenously, particularly because upregulation
of repeat sequences in the spleen appeared quite variable.
We note that elevated repetitive elements are detectable
in splenocytes from cancer-prone Tlr3, Tlr7, and Tlr9 tripledeficient mice (Yu et al., 2012), even though chromatindependent repression mechanisms are wild-type. This implies
that immune surveillance acts to eliminate wild-type cells
that sporadically express repetitive elements on an ongoing
basis, even if their repressive mechanisms are normal.
This may explain the high degree of variability in repeat
expression found in cells deficient for DNA-methylation- or
histone-methylation-dependent repressive mechanisms (Howard et al., 2008; Muotri et al., 2010; Wylie et al., 2016). In
this way, splenocytes of Rb1S/S mice may be poised to overexpress repeats but are eliminated by immune detection
mechanisms, preventing their accumulation and consistent
detection of repeat expression.
It is difficult to conclude that repeat expression alone causes
cancer in Rb1S/S mice. However, there are a number of reasons
to expect that a pRB-E2F1-EZH2 complex has cancer-relevant
properties. First, the preference for lymphomas and age of
onset in Rb1S/S mice phenotypically parallels E2f1/ mice
(Yamasaki et al., 1996). Missense alleles in human RB1 are
rare, so it is not surprising that the Rb1S allele is absent from
cancer genome datasets. However, a low penetrance RB1 family has been reported to possess exon 24 and 25 deletions
(Bremner et al., 1997) that eliminate pRB’s unique binding
domain for E2F1 (Cecchini and Dick, 2011; Julian et al.,
2008). Similarly, multiple instances of D295 substitutions in
DP1 (Munro et al., 2014) indicate that the unique contact point
for E2F1/DP1 with pRB is directly targeted in human cancers.
Lastly, other Rb1-targeted strains that compromise E2F transcriptional control at canonical cell-cycle target genes, such
as Rb1G/G (Cecchini et al., 2014), or that are prone to unstable
genomes related to defective chromatin condensation, as in
Rb1L/L and Rb1NF/NF mice (Coschi et al., 2010; Vormer et al.,
2014), are not spontaneously cancer prone. Because only
Rb1S/S cells misexpress repeat sequences among these genotypes, and repeat expression is most pronounced in the cancer-prone tissue of Rb1S/S mice, these data point to a very
strong correlation between defective pRB-EZH2 repeat suppression and cancer incidence.
Likely, the most significant implication for our work is
the relationship between RB1 status and the effects of EZH2
inhibitors. We anticipate that EZH2 inhibitors will cause
widespread de-repression of repetitive sequences in pRBpositive cancers, as reported for inhibitors of DNA methylation
(Chiappinelli et al., 2015; Roulois et al., 2015), and this
may offer a pathway to sensitize tumors to immunotherapy.
By extension, EZH2 inhibitors may have activity as anti-viral
agents because they may awaken latent viral genomes. This
manuscript reveals an exciting connection between a canonical tumor suppressor and heterochromatin formation that
further supports repetitive element silencing as a cancer-relevant process.

EXPERIMENTAL PROCEDURES
Cell Culture and Mice
MEFs were generated from E13.5 embryos and cultured as previously
described (Coschi et al., 2014). Cells were typically arrested by serum starvation. All mice were handled according to CCAC standards.
Chromatin Immunoprecipitation
Briefly, cross-linked chromatin sonicated to %400 bp was normalized
between experimental groups and pre-cleared with protein G Dynabeads, and ChIP antibodies were added to immunoprecipitate proteins.
Cross-links were reversed at 65 C, and samples were treated with
RNase and proteinase K. DNA was isolated for qPCR or library preparation, followed by single-end sequencing using Illumina HiSeq2500. See
Tables S1 and S2 for ChIP-qPCR primers. Further details of ChIPreChIP and ChIP-seq are available in the Supplemental Experimental
Procedures.
RNA Expression
Total RNA isolated with Trizol was DNaseI-treated and reverse transcribed
using random primers and Superscript III reverse transcriptase (Invitrogen).
qRT-PCR was performed using iQ SYBR green Super Mix (Bio-Rad). See
Supplemental Information for primer sequences. Expression microarray experiments can be found in GEO: GSE85640.
Analysis of ChIP-Seq and RNA-Seq Experiments
Sequence reads were mapped to the mm9 genome assembly, without allowing mismatches, as previously reported (Bulut-Karslioglu et al., 2014). Reads
with more than one exact match were randomly assigned among these locations. RNA-seq reads were mapped to a custom repeat index (Day et al.,
2010), assigning reads to their best match and allowing up to two sequence
mismatches. See Supplemental Information for computational analysis
details.
ACCESSION NUMBERS
The accession number for the sequence data reported in this paper is GEO:
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